Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013472
Filing Date
2020-11-10
Accepted
2020-11-10 08:00:49
Documents
59
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pasg-20200930x10q.htm 10-Q 1637860
2 EX-10.1 pasg-20200930ex101899b73.htm EX-10.1 23300
3 EX-31.1 pasg-20200930ex3111e1c4d.htm EX-31.1 10850
4 EX-31.2 pasg-20200930ex3128d0c6a.htm EX-31.2 10742
5 EX-32.1 pasg-20200930ex321ca9811.htm EX-32.1 5984
6 EX-32.2 pasg-20200930ex32270af18.htm EX-32.2 5964
7 GRAPHIC pasg-20200930ex101899b73001.jpg GRAPHIC 1659
8 GRAPHIC pasg-20200930x10q001.jpg GRAPHIC 47685
  Complete submission text file 0001558370-20-013472.txt   5660360

Data Files

Seq Description Document Type Size
9 EX-101.INS pasg-20200930.xml EX-101.INS 1091132
10 EX-101.SCH pasg-20200930.xsd EX-101.SCH 42955
11 EX-101.CAL pasg-20200930_cal.xml EX-101.CAL 38188
12 EX-101.DEF pasg-20200930_def.xml EX-101.DEF 154936
13 EX-101.LAB pasg-20200930_lab.xml EX-101.LAB 365072
14 EX-101.PRE pasg-20200930_pre.xml EX-101.PRE 270849
Mailing Address TWO COMMERCE SQUARE 2001 MARKET STREET, 28TH FLOOR PHILADELPHIA PA 19103
Business Address TWO COMMERCE SQUARE 2001 MARKET STREET, 28TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39231 | Film No.: 201299672
SIC: 2836 Biological Products, (No Diagnostic Substances)